
Mediflame AQ 75mg Injection
Marketer
In Med Therapeutics
Salt Composition
Diclofenac (75mg)
Overview Mediflame AQ 75mg Injection
Arthritis and acute musculoskeletal pain may be treated with the injectable analgesic, Mediflame AQ 75mg. This injectable formulation is indicated when oral medication is infeasible, targeting pain, inflammation, stiffness, and joint discomfort associated with conditions such as rheumatoid and osteoarthritis. Administration must be performed by a qualified medical professional; self-injection is strictly prohibited. Patients with a history of cardiovascular events (stroke or heart disease) should inform their physician prior to treatment. Report any injection site reactions (pain, swelling, redness) to your doctor immediately. Common adverse effects include nausea, vomiting, headache, and localized injection site reactions. Prolonged therapy may necessitate regular monitoring of renal and hepatic function, along with blood counts. Serious complications, including gastrointestinal bleeding and nephropathy, are potential risks associated with extended use.
Uses of Mediflame AQ 75mg Injection
Analgesia
Major Benefits of Mediflame AQ 75mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Mediflame AQ 75mg Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Flatulence
- Edema (swelling)
- Nausea
- Headache
- Dizziness
How to use Mediflame AQ 75mg Injection:
The medication will be administered by your physician or their assistant; please refrain from self-medication.
How Mediflame AQ 75mg Injection works:
Inflaquil 75mg injection, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for pain and the associated redness and swelling.
SAFETY ADVICE
AlcoholCAUTION
Use of Mediflame AQ 75mg Injection with alcohol requires careful consideration. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Mediflame AQ 75mg Injection to pregnant individuals poses a confirmed risk to the fetus. Its use during pregnancy is contraindicated, except in potentially life-threatening circumstances where the physician deems the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingCONSULT YOUR DOCTOR
Use of the injectable medication Mediflame AQ 75mg while breastfeeding is potentially hazardous. Available human data indicates a possibility of the drug transferring to breast milk, posing a risk to the infant.
DrivingUNSAFE
Administering Mediflame AQ 75mg Injection may induce adverse reactions potentially impairing driving capabilities.
KidneyCAUTION
For individuals with kidney impairment, administration of a 75mg Mediflame AQ Injection requires careful monitoring. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
For individuals with hepatic impairment, the administration of 75mg Mediflame AQ Injection requires careful monitoring. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Mediflame AQ 75mg Injection :
Omit a Mediflame AQ 75mg Injection dose? Seek your physician's advice.
Facts to Know About Mediflame AQ 75mg Injection
| Label | Value |
|---|---|
| Chemical Category | Phenylacetic acid derivative |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
